Ubs Group Ag Brainsway Ltd. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Brainsway Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 3,001 shares of BWAY stock, worth $46,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,001
Previous 28,072
89.31%
Holding current value
$46,395
Previous $265,000
85.28%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BWAY
# of Institutions
45Shares Held
5.76MCall Options Held
69.9KPut Options Held
0-
Valor Management LLC Chicago, IL2.1MShares$32.5 Million11.68% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$15.5 Million0.52% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L3362KShares$5.6 Million0.06% of portfolio
-
Acadian Asset Management LLC Boston, MA334KShares$5.17 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA301KShares$4.65 Million0.81% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $255M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...